BridgeBio Oncology Therapeutics, Inc.
BBOT
$8.48-4.29%
Delayed · as of Sep 9, 2026, 10:00 AM ET
Mkt cap
$610.42M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$3.55M
EPS (H1 2026)
$-1.37
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
-1589.81%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company listed on NASDAQ.
Latest reported BBOT revenue for 2026-06-30 was $3.6M. Net income was -$56.5M. Revenue was down 10.0% from 2026-03-31 to 2026-06-30. BBOT currently screens at market cap $610.4M.
Use this BBOT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BBOT income, balance, and cash tables.
BridgeBio Oncology Therapeutics, Inc. (BBOT) is a biotechnology company in the Healthcare sector.
Latest cached BridgeBio Oncology Therapeutics, Inc. (BBOT) revenue for Jun 30, 2026 was $3.6M. Net income was -$56.5M. Statements: https://lician.com/financials/bbot
BridgeBio Oncology Therapeutics, Inc. (BBOT) market capitalization is $610.4M on the latest cached snapshot.
BridgeBio Oncology Therapeutics, Inc. (BBOT) cached previous close $8.86; day range $8.46 – $8.86; volume 24,054. Session quote: https://lician.com/quote/bbot
BridgeBio Oncology Therapeutics, Inc. (BBOT) latest cached earnings event is "BBOT earnings" on Aug 11, 2026. Earnings calendar: https://lician.com/earnings